Table 3.
Comparison of Adverse Events During the First 14 d After Treatment, Comparing Two Treatments for PTE
| Adverse Events | rt-PA 100 mg (n = 48) | rt-PA 50 mg (n = 55) | P |
|---|---|---|---|
| Death | 3 (6) | 1 (2) | .472 |
| Due to PTE | 2 (4) | 1 (2) | … |
| Due to bleeding | 1 (2) | 0 (0) | … |
| Bleeding complications | 17 (32) | 11 (17) | .054 |
| Major bleeding | 5 (10) | 2 (3) | .288 |
| Fatal bleeding | 1 (2) | 0 (0) | … |
| Others | 4 (8) | 2 (3) | … |
| Minor bleeding | 12 (22) | 9 (14) | .214 |
| Recurrent PTE | 2 (4) | 1 (2) | .858 |
| Fatal | 0 (0) | 0 (0) | … |
| Nonfatal | 2 (4) | 1 (2) | … |
Data presented are number (%) of patients. Others = other major bleeding without death. See Table 1 for expansion of abbreviations.